RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 in Chronic Spontaneous Urticaria (CSU)
October 19, 2025 08:00 ET | Source: RAPT Therapeutics, Inc. SOUTH SAN…
Wialon Announces Top 10 GPS Hardware Manufacturers for 2025
DUBAI, UAE, Oct. 19, 2025 /PRNewswire/ -- Teltonika Telematics has once again been…
HKUST Holds Congregation 2025 Conferring Honorary Doctorates on Five Distinguished Leaders
HONG KONG, Oct. 18, 2025 /PRNewswire/ -- The Hong Kong University of…
Landis+Gyr Awarded EcoVadis Platinum Medal for the Second Consecutive Year for Outstanding Sustainability Performance
CHAM, Switzerland, Oct. 16, 2025 /PRNewswire/ -- Landis+Gyr Group AG (SIX: LAND), a…
Kaspersky Receives Frost & Sullivan’s 2025 META Competitive Strategy Leadership Recognition in Threat Prevention
The company is recognized for its operational excellence, stakeholder integration, and innovation…
Redfox Cybersecurity Founder Karan Patel Announces Strategic Expansion into Hospitality with Fairfield by Marriott Mumbai Andheri West
The Redfox Cybersecurity Founder and His Wife Urvashi Patel Announce Their Newest…
Precede Biosciences Presents New ESMO 2025 Data Demonstrating Its Liquid Biopsy Platforms Ability to Resolve Target Expression and Molecular Subtypes in Small Cell Lung Cancer
Small cell lung cancer (SCLC) accounts for 15% of all lung cancers…
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
Media Release COPENHAGEN, Denmark; October 18, 2025 Updated data from the Phase…
ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025
Study data also showed prolonged progression-free survival with 177Lu-edotreotide compared to everolimus…
DeFi crypto Mutuum Finance (MUTM) Onboards Over 17,300 Investors With 70% of Phase 6 Allocated
Dubai, UAE , Oct. 18, 2025 (GLOBE NEWSWIRE) -- The DeFi market…
